Effect of Lipopolysaccharide on Inflammation and Insulin Action in Human Muscle
Open accessThe DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Abstract
Accumulating evidence from animal studies suggest that chronic elevation of circulating intestinal-generated lipopolysaccharide (LPS) (i.e., metabolic endotoxemia) could play a role in the pathogenesis of insulin resistance. However, the effect of LPS in human muscle is unclear. Moreover, it is unknown whether blockade/down regulation of toll-like receptor (TLR)4 can prevent the effect of LPS on insulin action and glucose metabolism in human muscle cells. In the present study we compared plasma LPS concentration in insulin resistant [obese non-diabetic and obese type 2 diabetic (T2DM)] subjects versus lean individuals. In addition, we employed a primary human skeletal muscle cell culture system to investigate the effect of LPS on glucose metabolism and whether these effects are mediated via TLR4. Obese non-diabetic and T2DM subjects had significantly elevated plasma LPS and LPS binding protein (LBP) concentrations. Plasma LPS (r = -0.46, P = 0.005) and LBP (r = -0.49, P = 0.005) concentrations negatively correlated with muscle insulin sensitivity (M). In human myotubes, LPS increased JNK phosphorylation and MCP-1 and IL-6 gene expression. This inflammatory response led to reduced insulin-stimulated IRS-1, Akt and AS160 phosphorylation and impaired glucose transport. Both pharmacologic blockade of TLR4 with TAK-242, and TLR4 gene silencing, suppressed the inflammatory response and insulin resistance caused by LPS in human muscle cells. Taken together, these findings suggest that elevations in plasma LPS concentration found in obese and T2DM subjects could play a role in the pathogenesis of insulin resistance and that antagonists of TLR4 may improve insulin action in these individuals.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In metabolic disorders, elevated LBP and sCD14 frequently accompany insulin resistance, thus supporting the concept of “metabolic endotoxemia” driven by dysbiosis.141,142”
From Gut dysbiosis in oncology: a risk factor for immunoresistance (2026) · doi:10.1038/s41422-025-01212-6 · cites this paper as [142]
In the citing paper
“These studies and others [30, 37], show that circulating LPS, a prominent component of gut microbiota, induces skeletal muscle inflammation and insulin resistance thereby contributing to the development of metabolic syndrome.”
From Gut Microbiota Contribute to Age-Related Changes in Skeletal Muscle Size, Composition, and Function: Biological Basis for a Gut-Muscle Axis (2018) · cites this paper as [37]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Dual Role of Interleukin-6 in Regulating Insulin Sensitivity in Murine Skeletal Muscle
Nieto-Vazquez, I., Fernández-Veledo, S., de Alvaro, C., & Lorenzo, M. (2008) · Diabetes · doi:10.2337/db07-1062 · Cited by 209 · cited 1×
“IL-6 also has been reported to impair insulin signaling at the level of IRS-1 through the activation of JNK and suppressor of cytokine signaling (SOCS)-3, and tyrosine dephosphorylation by protein tyrosine phosphatase 1B [24].”
BackgroundRetractedGlucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Metabolic Endotoxemia Initiates Obesity and Insulin Resistance
Cani, P. D., Amar, J., Iglesias, M. A., Poggi, M., Knauf, C., Bastelica, D., Neyrinck, A. M., Fava, F., Tuohy, K. M., Chabo, C., et al. (2007) · Diabetes · doi:10.2337/db06-1491 · Cited by 6,638
Inflammation and insulin resistance
Shoelson, S. E. (2006) · Journal of Clinical Investigation · doi:10.1172/jci29069 · Cited by 4,769
TLR4 links innate immunity and fatty acid-induced insulin resistance
Shi, H., Kokoeva, M. V., Inouye, K., Tzameli, I., Yin, H., & Flier, J. S. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28898 · Cited by 3,690 · cited 1×
“disrupted expression of TLR4 protects mice from developing inflammation and insulin resistance in response to chronic changes in dietary fat [12].”
BackgroundKawai, T., & Akira, S. (2006) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401850 · Cited by 1,810
DeFronzo, R. A., Jacot, E., Jequier, E., Maeder, E., Wahren, J., & Felber, J. P. (1981) · Diabetes · doi:10.2337/diab.30.12.1000 · Cited by 1,770
Aguirre, V., Uchida, T., Yenush, L., Davis, R., & White, M. F. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.12.9047 · Cited by 1,487
Receptor-Dependent Mechanisms of Cell Stimulation by Bacterial Endotoxin
Ulevitch, R. J., & Tobias, P. S. (1995) · Annual Review of Immunology · doi:10.1146/annurev.iy.13.040195.002253 · Cited by 1,442 · cited 1×
“When LBP and sCD14 are absent, a much higher LPS concentration is required to exert its cellular effects [36,37].”
BackgroundCreely, S. J., McTernan, P. G., Kusminski, C. M., Fisher, F. M., Da Silva, N. F., Khanolkar, M., Evans, M., Harte, A. L., & Kumar, S. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00302.2006 · Cited by 1,043 · cited 1×
“Recent studies have also demonstrated elevated plasma LPS concentration in some groups of obese and T2DM subjects [3,4].”
Background
Cited by
Skeletal muscle: A review of molecular structure and function, in health and disease
Mukund, K., & Subramaniam, S. (2020) · WIREs Systems Biology and Medicine · doi:10.1002/wsbm.1462 · Cited by 664
Grosicki, G. J., Fielding, R. A., & Lustgarten, M. S. (2018) · Calcified Tissue International · doi:10.1007/s00223-017-0345-5 · Cited by 388
“These studies and others [30, 37], show that circulating LPS, a prominent component of gut microbiota, induces skeletal muscle inflammation and insulin resistance thereby contributing to the development of metabolic syndrome.”
BackgroundGlucose requirements of an activated immune system in lactating Holstein cows
Kvidera, S. K., Horst, E. A., Abuajamieh, M., Mayorga, E. J., Fernandez, M. V. S., & Baumgard, L. H. (2017) · Journal of Dairy Science · doi:10.3168/jds.2016-12001 · Cited by 363
Kellow, N. J., Coughlan, M. T., & Reid, C. M. (2014) · British Journal of Nutrition · doi:10.1017/s0007114513003607 · Cited by 307
“LPS stimulates the overproduction of reactive oxygen species and pro-inflammatory cytokines by macrophages, resulting in subclinical systemic inflammation, weight gain and insulin resistance development((65,66)).”
BackgroundMorris, G., Berk, M., Carvalho, A., Caso, J. R., Sanz, Y., Walder, K., & Maes, M. (2017) · Molecular Neurobiology · doi:10.1007/s12035-016-0004-2 · Cited by 307
Metadata
- Authors
- Liang, H., Hussey, S. E., Sanchez-Avila, A., Tantiwong, P., & Musi, N.
- Affiliations
- The University of Texas at San Antonio Health Science Center (US)
- Corresponding author
- Musi, Nicolas
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2013-05-21
- Volume
- 8
- Issue
- 5
- Pages
- e63983
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3660322
- OpenAlex
- W2048244595
- Cited by
- 215
- References
- 40
- Citations by year
- 2026: 22 · 2025: 12 · 2024: 21 · 2023: 22 · 2022: 19 · 2021: 18 · 2020: 20 · 2019: 14 · 2018: 12 · 2017: 17 · 2016: 9 · 2015: 15 · 2014: 11 · 2013: 3
- FWCI
- 9.23
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- American Diabetes Association
- National Institutes of Health (UL1TR001120, 8ul1tr000149-05)
- University of Texas Health Science Center at San Antonio
- National Institute of Diabetes and Digestive and Kidney Diseases (F32DK095565, R01DK089229, R01DK080157, R01-DK80157)
- National Center for Advancing Translational Sciences (UL1-TR000149, TR000149)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Keywords
- lipopolysaccharide, endotoxemia, insulin resistance, skeletal muscle, TLR4, TAK-242, inflammation, glucose metabolism, IRS-1, Akt, AS160, JNK phosphorylation, MCP-1, interleukin-6, LPS-binding protein, obesity, type 2 diabetes, insulin sensitivity
- MeSH terms
- Lipopolysaccharide-Binding Protein, Acute-Phase Proteins, Adult, Carrier Proteins, Humans, Inflammation, Insulin, Insulin Resistance, Lipopolysaccharides, Membrane Glycoproteins, Middle Aged, Solubility, Sulfonamides, Signal Transduction, Muscle, Skeletal, Muscle Fibers, Skeletal, Lipopolysaccharide Receptors, Gene Silencing, Toll-Like Receptor 4
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Effect of Lipopolysaccharide on Inflammation and Insulin Action in Human Muscle. https://app.cochat.ai/papers/10.1371/journal.pone.0063983
- The paper
- Liang, H., Hussey, S. E., Sanchez-Avila, A., Tantiwong, P., & Musi, N. (2013). Effect of Lipopolysaccharide on Inflammation and Insulin Action in Human Muscle. PLoS ONE. https://doi.org/10.1371/journal.pone.0063983
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.